R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Patentability and predictability in AI-assisted drug discove...

Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.

R&D

Transforming clinical data management systems for biotechnol...

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated.

R&D

JP Morgan 2024 – Jonah Comstock interview with Xavier Duportet

JP Morgan 2024 – Xavier Duportet

There were plenty of gene therapy companies around at JP Morgan 2024, and more than a few companies focused on the microbiome.

R&D

Patterns of behaviour: Using AI-based algorithms to improve ...

For those of us old enough to remember ringing in the year 2000, current concerns that artificial intelligence (AI) may usher in the end of the world as we know it may call to mind the fear

R&D

Pharmaceutical research in space

When US President Joe Biden talks about his Cancer Moonshot, he's not literally talking about the moon - he's referencing the legendary innovation push that got Americans to the moon in 196

R&D

JP Morgan interview with Jonah Comstock and Marianne De Backer

JP Morgan 2024 – Marianne De Backer

Vir Biotechnology made headlines in 2021 for its work with GlaxoSmithKline on a treatment for COVID-19, and again in 2022 for its work with the US government on influenza.